Behavioral and molecular studies have established a link between drugs of abuse and the central melanocortin system, particularly the melanocortin 4 receptor (MC4-R). The present study expands this line of investigation to characterization of the neurochemical and behavioral interactions between MC4-R and the psychomotor stimulant, cocaine. The results demonstrate that repeated, but not acute, cocaine administration upregulates MC4-R mRNA expression in the striatum and hippocampus, but not cerebral cortex. Pharmacological studies indicate that the up-regulation of MC4-R expression occurs via dopamine D 1 and D 2 receptor-dependent mechanisms. The D 1 /D 2 antagonist haloperidol and the D 2 -selective antagonist eticlopride mimic the effect of cocaine on MC4-R expression. In addition, coadministration of a D 1 -selective antagonist, SCH 23390 [R-(ϩ)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine], completely blocks the up-regulation of MC4 mRNA by cocaine, demonstrating that D 1 receptor activation is necessary for this response. Moreover, the results demonstrate that cocaine treatment increases behavioral responses (grooming and locomotor activity) to infusions of a melanocortin agonist, indicating that up-regulation of MC4-R expression results in functional consequences. These data further support a role for the melanocortin-MC4-R neuropeptide system in the biochemical and behavioral effects of cocaine.Pro-opiomelanocortin (POMC) serves as a precursor for a number of neuropeptides, including the melanocortins, ␣-, -, and ␥-melanocyte-stimulating hormone (MSH), and adrenocorticotrophic hormone, as well as -endorphin. POMC-expressing neurons are located in the pituitary, the arcuate nucleus of the hypothalamus, and the nucleus of the solitary tract; and the latter two structures send projections to a number of different brain regions, including the mesolimbic dopamine system (Jacobowitz and O 'Donohue, 1978;Eskay et al., 1979). The melanocortin neuropeptides are reported to influence a variety of behavioral and neuroendocrine systems via regulation of central nervous system centers, including grooming, thermoregulation, and learning (Alvaro et al., 1997). The actions of melanocortins are mediated via activation of melanocortin receptors, of which there are five subtypes, all of which belong to the G-protein-coupled receptor superfamily. Two of these, melanocortin-3 and -4 (MC3-R and MC4-R) are expressed in significant levels in the brain and are thereby thought to mediate the central actions of melanocortin neuropeptides.Melanocortins are also reported to play a role in the behavioral and neurochemical actions of opiates, psychostimulants, and alcohol. Early studies indicated that melanocortin treatment could antagonize opiate tolerance and dependence, and even induce opiate withdrawal-like effects in naive animals (Szekaly et al., 1979;Contreras and Takemori, 1984). A preliminary study also found that a selective MC4-R antagonist attenuates the signs of morphine withdrawal tha...